During the past decade, Specializovana nemocnica sv. Svorada Zobor, n.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specializovana nemocnica sv. Svorada Zobor, n.o." are "Non-Small Cell Lung Cancer" (2 trials), "Atrial Fibrillation" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Specializovana nemocnica sv. Svorada Zobor, n.o." in a lesser frequency.

Most popular intervention types in "Specializovana nemocnica sv. Svorada Zobor, n.o." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specializovana nemocnica sv. Svorada Zobor, n.o." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Specializovana nemocnica sv. Svorada Zobor, n.o.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specializovana nemocnica sv. Svorada Zobor, n.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specializovana nemocnica sv. Svorada Zobor, n.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".